SCHEMBL4048307

SCHEMBL4048307

COc1cccc(C2CC2C(=O)Nc2sc3c(c2C#N)CCN(C(=O)O)C3)c1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
MEN1 O00255 5/20 0.61
KMT2A Q03164 5/20 0.61
MAPT P10636 4/20 0.61
KDM4E B2RXH2 2/20 0.53
GRM1 Q13255 3/20 0.51
STAT3 P40763 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
GRM5 P41594 3/20 0.47
MGAT2 Q10469 1/20 0.44
DGAT2 Q96PD7 1/20 0.44
LMNA P02545 1/20 0.43
HPGD P15428 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
HSD17B10 Q99714 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
MAPK10 P53779 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4767801 0.91 MEN1 (0.59) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL4766102 0.91 MEN1 (0.58) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL4777490 0.90 MEN1 (0.57) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL2896268 0.90 ALDH1A1 (0.57) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL4775622 0.89 ALDH1A1 (0.58) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL4773187 0.87 MEN1 (0.54) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL13239802 0.86 MEN1 (0.52) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL4775702 0.86 MEN1 (0.52) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL2893932 0.86 MEN1 (0.52) ALDH1A1MEN1KMT2AMAPTKDM4E
SCHEMBL4773298 0.85 MEN1 (0.52) ALDH1A1MEN1KMT2AMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2051983-A1 NTETRAHYDROPYRIDOTHIOPHENE DERIVATIVES FOR THE TREATMENT OF CANCER 4SC AG (DE) 2009-04-29 EP disclosed
WO-2008020024-A1 NTETRAHYDROPYRIDOTHIOPHENE DERIVATIVES FOR THE TREATMENT OF CANCER 4SC AG (DE) 2008-02-21 WO disclosed